BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23535315)

  • 21. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
    Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
    Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of PET/CT in the prognosis of extranodal NK/T cell lymphoma].
    Dong GH; Li Y; Wan HF; He CY; Yang L; Wang JW; Gong LP; Zhao YH; Gao ZF; Liu HG
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1256-1260. PubMed ID: 29747315
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
    Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ
    Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance.
    Wu RY; Liu K; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Ren H; Fang H; Liu QF; Yang Y; Chen B; Qi SN; Lu NN; Tang Y; Tang Y; Li N; Ouyang H; Li YX
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):50-59. PubMed ID: 27816363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].
    Chen F; Shen CX; Wang HG; Li GX; Wang XQ; Wen Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):327-333. PubMed ID: 29871255
    [No Abstract]   [Full Text] [Related]  

  • 27. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
    Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
    Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
    Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
    J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
    Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
    Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
    Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
    Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
    Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
    Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
    Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
    Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
    Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
    Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
    Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.